Recently, the combined usage of interscalene brachial plexus block with general anesthesia (ISB/GA) was reported to have a lower incidence of adverse side effects than GA alone. However ...

Results showed brachial plexus block with liposomal bupivacaine correlated with significantly decreased pain scores through 48 hours compared with placebo (136.4 vs. 254.1).

The Food and Drug Administration (FDA) has approved the use of Exparel (bupivacaine liposome injectable suspension; Pacira Pharmaceuticals) as an interscalene brachial plexus block to produce ...